2/28
11:22 am
zbio
Zenas BioPharma, Inc. (ZBIO): A Bull Case Theory [Yahoo! Finance]
Low
Report
Zenas BioPharma, Inc. (ZBIO): A Bull Case Theory [Yahoo! Finance]
2/21
02:04 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) was upgraded by analysts at
Wall Street Ze
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) was upgraded by analysts at
Wall Street Ze
2/20
04:15 pm
zbio
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/17
10:46 am
zbio
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
Low
Report
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
2/12
06:56 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
2/10
08:05 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $44.00 price target on the stock.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $44.00 price target on the stock.
2/9
07:05 am
zbio
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
Medium
Report
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
2/4
07:05 am
zbio
Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Low
Report
Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
2/3
01:54 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zenas BioPharma, Inc. – ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zenas BioPharma, Inc. – ZBIO
1/29
10:00 am
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/27
01:22 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/22
10:00 am
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/20
01:24 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/16
07:02 pm
zbio
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
1/16
04:15 pm
zbio
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1/15
10:00 am
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/13
03:53 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/13
01:36 am
zbio
Assessing Zenas BioPharma (ZBIO) Valuation After Positive INDIGO Phase 3 Trial News [Yahoo! Finance]
High
Report
Assessing Zenas BioPharma (ZBIO) Valuation After Positive INDIGO Phase 3 Trial News [Yahoo! Finance]
1/10
01:07 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) was downgraded by analysts at
Wall Street
High
Report
Zenas BioPharma (NASDAQ:ZBIO) was downgraded by analysts at
Wall Street
1/8
10:16 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/8
10:00 am
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/7
07:12 pm
zbio
Zenas BioPharma Touts Phase 3 Win, But Stock Crashes [Yahoo! Finance]
Low
Report
Zenas BioPharma Touts Phase 3 Win, But Stock Crashes [Yahoo! Finance]
1/6
12:50 pm
zbio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
1/6
12:41 pm
zbio
ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study [Yahoo! Finance]
Medium
Report
ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study [Yahoo! Finance]
1/6
07:17 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..